299MO Efficacy and safety of entrectinib in an Asian population with NTRK fusion-positive (fp) solid tumours or ROS1-fp NSCLC

Details

Request a copyRequest a copy
Serval ID
serval:BIB_FAA74E955403
Type
Article: article from journal or magazin.
Collection
Publications
Institution
Production externe
Title
299MO Efficacy and safety of entrectinib in an Asian population with NTRK fusion-positive (fp) solid tumours or ROS1-fp NSCLC
Journal
Annals of Oncology
Author(s)
Tan D.S.W., Ahn M-J., Chiu C-H., Ohe Y., Loong H.H.F., Chee C.E., Kim S-W., Takeda M., Li Y-C., Cheng A., Hida T., Kim D-W., Nogami N., Su W-C., Tanaka H., Osborne S., Freund R., Chen D., Seto T.
ISSN
0923-7534
Publication state
Published
Issued date
11/2020
Volume
31
Pages
S1358-S1359
Language
english
Keywords
Oncology, Hematology
DOI
10.1016/j.annonc.2020.10.293
Web of science
000600988900303
Open Access
Yes
Funding(s)
Fondation Hoffmann-La Roche Ltd.
Create date
04/07/2023 12:57
Last modification date
05/07/2023 5:54
Usage data